Global X Genomics & BiotechnGNOMETF

13F holders, Q1 2024 (March 31)
1holders
$11.38avg. 13F price*

At the end of Q1 2024, 1 institutions reported holding Global X Genomics & Biotechn (GNOM) in their 13F filings. The largest holder was Raffa Wealth Management, LLC ($11K).

Company
Global X Genomics & Biotechn
CUSIP
37960A214
Latest filing quarter
Q2 2026

History

Number of 13F holders

01020304050 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 2Q4 2024Q1 2025: 2Q1 2025Q2 2025: 2Q2 2025Q3 2025: 43Q3 2025Q4 2025: 40Q4 2025Q1 2026: 40Q1 2026Q2 2026: 48Q2 2026

Total Exit/New Position Q1 2024

No earlier quarter to compare with.

Ownership 1 holders

Raffa Wealth Management, LLC 0.00% No change 1,007 $11K

"% of holder's portfolio" is GNOM's weight in each manager's 13F, not the share of Global X Genomics & Biotechn the manager owns.